Liljelind Ingrid E, Michel Ingegerd, Damm Maria, Eriksson Kåre A
Occupational Medicine, Department of Public Health and Clinical Medicine, Umeå University, S-901 87 Umeå, Sweden.
Ann Occup Hyg. 2007 Jun;51(4):407-13. doi: 10.1093/annhyg/mem015. Epub 2007 Apr 24.
Although corticosteroids have been used for over 50 years as anti-inflammatory and anti-proliferative agents, few studies have examined their exposure levels and health effects on workers employed in the corticosteroid manufacturing industry. The aims of the study reported here were to develop a tape-stripping technique for monitoring budesonide (a corticosteroid used in inhalators for treating respiratory diseases) and to apply the method in a pilot study to estimate the potential dermal exposure to budesonide among workers at a pharmaceutical formulation site.
The tape-stripping method was evaluated by applying 0.5 and 2.07 microg of budesonide dissolved in ethanol on tape strips. The same amounts were also applied on a cleaned glass plate and human skin of volunteers, which were then stripped by series of tapes immediately, and 30 min later, the amounts collected by the tapes were measured. Finally, the technique was used to study the exposure of budesonide among eight employees at a pharmaceutical industry site. Three exposure sites were tested: the tip of the forefinger, palm of the hand and ventral part of the lower arm. Five consecutive tape strips per sampling site were used in both the recovery studies and the field study.
The mean overall recoveries from spiked tapes and the glass plate were 96 and 81%, respectively, while for human skin the corresponding figure was 38%, (for applications of 2.07 microg; no detectable amounts were recovered from human skin after 0.5 microg applications). The recovered amount was found on two consecutive tapes after 0 min, but only on the first tape strip after 30 min. The inter-individual variability was 4-fold. In the field, quantifiable amounts were found for four of eight employees and a concentration gradient was detected along the two or three consecutive tape strips. The tip of the forefinger and the palm of the hand were the most highly exposed sites to budesonide.
A tape-stripping method can be used to determine potential dermal exposure to budesonide. The results also indicate that budesonide is taken up by the skin of operators who are exposed to the substance at their workplace.
尽管皮质类固醇作为抗炎和抗增殖药物已使用了50多年,但很少有研究考察其在皮质类固醇制造行业工人中的暴露水平及其对健康的影响。本文报告的研究目的是开发一种胶带剥离技术,用于监测布地奈德(一种用于治疗呼吸道疾病的吸入用皮质类固醇),并在一项初步研究中应用该方法,以估计制药制剂场所工人皮肤接触布地奈德的潜在暴露量。
通过将0.5微克和2.07微克溶解在乙醇中的布地奈德涂在胶带条上来评估胶带剥离法。相同的量也涂在清洁的玻璃板和志愿者的人皮肤上,然后立即用一系列胶带进行剥离,并在30分钟后测量胶带收集的量。最后,该技术用于研究制药行业场所八名员工中布地奈德的暴露情况。测试了三个暴露部位:食指尖、手掌和下臂腹侧。在回收率研究和现场研究中,每个采样部位均使用连续五条胶带。
加标胶带和玻璃板的平均总回收率分别为96%和81%,而人皮肤的相应回收率为38%(对于2.07微克的应用;0.5微克应用后未从人皮肤中回收可检测量)。在0分钟后,在连续两条胶带上发现了回收量,但在30分钟后仅在第一条胶带上发现。个体间差异为4倍。在现场,八名员工中有四名检测到可量化的量,并在连续的两到三条胶带上检测到浓度梯度。食指尖和手掌是布地奈德暴露最高的部位。
胶带剥离法可用于确定皮肤接触布地奈德的潜在暴露量。结果还表明,在工作场所接触该物质的操作人员的皮肤会吸收布地奈德。